{
  "title": "Systems Biology Analysis of the response to  Licensed Hepatitis B Vaccine (Engerix-B) (see companion study SDY690)",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY89",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Systems Biology Analysis of the response to  Licensed Hepatitis B Vaccine (Engerix-B) (see companion study SDY690)",
  "performedBy": [
    {
      "firstName": "Robert",
      "lastName": "Coffman",
      "email": "rcoffman@dynavax.com",
      "affiliations": [
          {
             "name": "Dynavax Technologies Corporation"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Energix-B",
          "size": 50
        }
  ],
  
  "usesReagent": [
        {
          "name": "Vitros Anti-HBs Reagent pack/Vitros Anti-HBs assay"
        },
        {
          "name": "CD138"
        },
        {
          "name": "CD14"
        },
        {
          "name": "CD19"
        },
        {
          "name": "CD20"
        },
        {
          "name": "CD24"
        },
        {
          "name": "CD27"
        },
        {
          "name": "CD38"
        },
        {
          "name": "IgD"
        },
        {
          "name": "CD3"
        },
        {
          "name": "CD86"
        },
        {
          "name": "VIVID"
        },
        {
          "name": "CD3"
        },
        {
          "name": "B cell panel"
        },
        {
          "name": "CCR7"
        },
        {
          "name": "CD14"
        },
        {
          "name": "CD16"
        },
        {
          "name": "CD20"
        },
        {
          "name": "CX3CR1"
        },
        {
          "name": "SLAN"
        },
        {
          "name": "CD2"
        },
        {
          "name": "CD40"
        },
        {
          "name": "HLA-DR"
        },
        {
          "name": "Monocyte panel"
        },
        {
          "name": "BDCA-2"
        },
        {
          "name": "BDCA-3"
        },
        {
          "name": "CD11c"
        },
        {
          "name": "CD1c"
        },
        {
          "name": "Lin-1"
        },
        {
          "name": "D cell panel"
        },
        {
          "name": "CCR6"
        },
        {
          "name": "CD4"
        },
        {
          "name": "CD45RA"
        },
        {
          "name": "CD8"
        },
        {
          "name": "CXCR3"
        },
        {
          "name": "CXCR5"
        },
        {
          "name": "ICOS"
        },
        {
          "name": "PD-1"
        },
        {
          "name": "TFH panel"
        },
        {
          "name": "GX-BeadChip HT12v4"
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Robert",
      "lastName": "Coffman",
      "email": "rcoffman@dynavax.com",
      "affiliations": [
          {
             "name": "Dynavax Technologies Corporation"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI089987"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Our goal is to identify early biomarkers of effective antibody responses to flu vaccination. Four aims are proposed to meet this goal: Aim 1: To establish the baseline immune profiles in healthy subjects. Aim 2: To establish the immune profiles of Flu vaccination in healthy subjects. Aim 3: To identify the molecular signatures of DC subset(s) in response to Flu vaccination. Aim 4: To identify the molecular signatures of activated monocytes in response to Flu vaccination. RELEVANCE (See instructions): Despite the success of vaccines, we understand little about how effective ones stimulate protective immune responses. We will study how the flu vaccine generates effective antibody responses. The goal is to identify the immune responses elicited by effective vaccines so that vaccines that aren't as effective can be improved. To do this, we will vaccinate healthy people with the flu vaccine and monitor their immune response following the vaccination.   http://projectreporter.nih.gov/project_info_details.cfm?aid=8691692&icde=23828587&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Interventional"
      },
      {
        "value": "Immune Response"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2016-03-18",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Neutralizing Antibody Titer"
        },
        "description": "None",
        "types": [
            {
               "value": "Virus Neutralization"
            }
        ]
      },{
        "name": {
            "value": "Cellular Phenotype"
        },
        "description": "None",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Molecular Activity"
        },
        "description": "None",
        "types": [
            {
               "value": "Array"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "None"
        },
        {
          "name": "HIPC_P3_ENGX_NONE"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY89",
              "identifierSource": "ImmPort"
          },
          "title": "Systems Biology Analysis of the response to  Licensed Hepatitis B Vaccine (Engerix-B) (see companion study SDY690)",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY89",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8259851&icde=23826717&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "This project will contribute to the overall vision and goals of this U19 by analyzing the role of adjuvants in the humoral response to hep B vaccination in healthy individuals."
}
